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in 6 centers participating in the Medicare Heart Bypass Demonstration were 
analyzed by quantitative computeflzed coronary angiagrapby (QCA). QCA 
estimates of % stenosls (% St) in 350 lesions were compared to hospitals' 
visual estimates (HV). 
HV-QCA differences L, etween hospitals were significant (p < 0.01) after 
controlling for pt charactedstius in multiple regression analyses. 
CencJus/ons: Hospitals vary widely in the magnitude of the discrep~ulcy 
between visual and objective computerized estimates of % St and in the 
proportion of critical esions =,danflfied. This large variability between hoepitais 
has potentially important |nlpUcatione with regard Io the decision making 
threshold to perform CABG. Improved standardization of the methods u,~ed 
to interpret coronary angiagrams is needed. 
~-~The Pedcardlal Valve in the Small Aortic Edwards 
Root: Hemodynamics and Evidence for Regression 
of  Hypertrophy 
Stsven Khan, Ashish Parikh, Shalla Kar, Michele DeRobertis, 
Aurello Chats, Robert Siegel. C, edam-Sinai Medical Center, Los Angeles, 
CA 
Traditionally, tissue valves have not been implanted in patients with small 
aortic roots (SAR) due to poor hemodynamki performance. However, the 
improved hamodynamics of the Carpontier-Edwards padcardial valve (CEP) 
have led to its use in SAR patients who previously would have received 
mechanical valves, lo  evaluate the late hemodynamio performance of the 
CEP valve and regression of left ventdcular hypertrophy (LVH) we StL¢lied 37 
patients at least one year (mean 19 months) after AVR by ecllec~m'iographic 
and EKG criteria. 
Results: 
Valve Hemodynamtcs Valve Size (ram) 
19(n=4) 21(n=21) 23(n=12) 
Valve Area (cm 2) 1.1 1.3 1.5 
Mean Gradient (mmHg) 18.5 18.5 15.7 
VtN2 Ratio 0.43 0.42 0.48 
Peak and mean gredients decreased from 81 to 29 mmHg and from 48 to 18 
mmHg respectively. The mean LVEDD and LVESD decreased from 4.7 crn to 
4A crn and from 3.0 to 2.9 (both P < 0.05). Mean septai thickness decreased 
from 1.30 cnl to 1.17 cm (P < 0.01 ). Mean posterior wail thickness decreased 
from 1.27 cm to 1.12 cm (P = 0.02) while ejection fraction increased from 
61% to 66%. EKG LVH was present in 69% of patients preoperatively and 
430 postoperatively. 
Conclusion: The CE Pedcardiai valve demonstrates good hemodynamic 
performance at one year after surgery in patients with small aortic roots. 
There is corresponding evidence of regression of LVH by bath echo and 
EKG cdteda. 
~ Mitral Valve Repair in Elderly: Degenerative the 
Versus Ischemic Mltral Regurgitation 
Antone J. Tatooles, Saw R Aranki, David H. Adams, Gregory S. Couper, 
Robert J. Rizzo, John J. Collins, Lawrence H, Cohn. Brigham and Women's 
Hosp/ta/, Boston, MA 
The clinical outcome for elderly patients (> 70) undergoing mitral valve repair 
for mitral regurgitation (MR) is asyet undefined. From 1/85-1/95 155 patients 
>_ 70 years of age underwent mitral valve repair for either dagenemtive mitral 
mgurgitetion (DMR) 114 patients, or ischemlo mitrai regurgitation (IMR) 41 
patients. Associated CABG was done in 39141 IMR patients and 44/114 
DMR patients. In the IMR group 49% were functional class IV and 41% had 
an ejection fraction below 40% versus the DMR group in which 16% were 
functional class IV and 3% had an ejection fraction below 40%. The operative 
mortality for DMR was 4/114 (3.5%) vemus 9141 for IMR (22%) (p < 0.005). 
Long term follow-up indicated freedom from thromboemboli was 93% in DMR 
group versus 92% in IMR group without anti-coagulation; 10/110 surviving 
DMR patients required moperatlon (9%). 
These results demonstrate mitral valve repair In the elderly for degener- 
ative mitral regurgitation an be carded out at low dsk and excellent long 
term results. In contrast repair of the degenerative Ischemic mitrai valve has 
a significant early operative mortality. Better selection of patients, particu- 
lady in the elderly group seems warranted in patients with ischemic mitral 
regurgitation. 
• Differential Alterations of Type Ig and W Collagen 
Protein Expression in Experimental Venous 
Bypass Grafting 
Bdan H. Annex, Stephan M. Denning, Gregory C. Fulton, Keith 
,A. Channon, Mark G. Davies, Per-Otto Hagen. Divisions of Cardiology and 
Exl:~.rirnental Surgery, Duke University Medical Center, Durham, NC 
1,'lti,-nal hyperplasia (IH) is the precursor of vein graft (VG) atherosclero- 
sis. Collagens am a family of genetically distinct proteins which accumulate 
dunng the development of IH and VG athemsderosis. Using immunohis- 
fochemical techniques, we examined changes in collagen III (fibdllar) and 
IV (basement membrane) protein expression following interpositional venous 
bypass graffing in rabbits. Control jugular veins (CV, n = 6) and VGs harvested 
3 days (n = 6), 7 days (n = 3) and 28 days (n = 4) after surgery were studied 
to represent ordferent s sges in the development of IH. The specir~ties of the 
anticollagen antibodies were confirmed on histclegic sectmns nt rabbit skin. 
In CV, collagen IV was expressed over the entire (100%) intima. In the 3 
day VG (pre-IH), collagen IV was expressed over approximately 50% of the 
Intimai area and was notably absent in regions of inflammatory infiltration. In 
the 7 day VG (early IH), collagen IV was entirely absent in the inttma, bot, in 
the 29 day VG (maximal IH) collagen IV was expressed over most (>75%) 
of the area of intima. In striking contrast, collagen III was absent in the intima 
of the control, 3 day and 28 day VGs but was faintly detected in the inflma 
of the 7 day VG. In conclusion: Collagen subtypes express different patterns 
of change in response to venous bypass grafting. In particular, collagen IV 
demonstrates dramatic alterations in protein expression dudng the formation 
of IH which may provide unique targets for therapy. 
[~- '~  22-Year Rates of  Crossover and Reoperation in the 
VA Cooperative Study of  Coronary Artery Bypass 
Surgery for  Stable Angina 
Peter Peduzzi, Katherine Detre, Ayumi Kamina. VA Coeperative Studies 
Program, West Haven, CT 
The VA randomized trial of medical (M) vs surgical (S) therapy enrolled 
686 patients (354 M, 3,32 S) between 1972-74 who had stable angina 
and angiographloaily documented coronary artery disease (50% cdtedon). 
Median follow-up was 21 years; 18 patients were lost to follow-up. 312 
S patients had bypass surgery (operate mortality = 5.8%) a,d 78 had 
second surgery (operative mortality = 10.3%). 160 M patients crossed over 
to S in 22 years (operative mortality = 4.4%) arid 33 had second surgery 
(operailve mortality = 9.1%). Ranpemtion and crossover ates were evaluated 
in angiographie (eng.) and clinical subgroups of patients without left main 
disease. Ang. high dsk was defined as 3-vessel diseese with impaired left 
ventdcular function; all others were dassitlod as low dsk. Low, mid and high 
clinical dskgroups were based on a multivadste risk function using 4 baseline 
factors: resting ST segment depression, history of MI, history of hypertension 
and New York Heart Functional Class III + IV vs I + I1.22-ynar cumulative 
rates were: 
M Crossover S Reoperatien 
N Rate N Rate 
All pts 354 0.66 332 0.45 
Ang. low dsk 211 0,63 210 0.45 
Ang. high risk 97 0.69 71 0.46 
Clinical low risk 123 0.64 113 0.48 
Clinical mid risk 91 0.66 84 0.44 
Clinical high dsk 94 0.57 83 0.43 
We conclude that crossover and reepemtion rates were not related tO 
baseline risk. Operative mortality was two times higher for reoperatlen. 
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~4~'~ Activated Plateleta From Heart Patients Transplant 
on Cyclespodne Therapy Release Free Radicals 
That Impair Platelet-Mediated 
Endathellum-D~-kendent Vseodilatation 
Heigi J. Oskarsson, 11mothy H~.{::leyer, Maria-Teresa Olivan. University of 
Nebraska Medi~' Cent~, Omaha, NE 
Cyclospodne (CyA) impaira the ability of platolets to mediate vasodistion, 
both in vitro and in vlvo. The purpose of this study was to elucidate the 
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patients (HT pits) on CyA therapy and healthy volunteers (NL pits). When 
CyA pitS and NL pits (1 x 10 a cellgml) were thrombin activated and perfused 
through a quiescent, N~-nltm-L-arglnine pre-treated normal rabbit carotid 
artery, pits caused a similar degree of vasoconstriction: -8.9 ± 2% vs. -8.8 
± 2% change in vessel diameter (CIVD), respectively (n = 7, p = NS). There 
was no dilferanco in the amount of ADP released into the supematar-tt of 
thromhin activated CyA pits and NL pits. However, while NL pits had no effect, 
activated CyA pits impaired endO~eflurn-dopendent vesedifation mediated 
by graded doses of abfuminally applied acetylcholine (Ach): 6 + 6% vs. 17 
5=/o, t3 :E g% vs. 44 4-13% and 43:1:13°/= vs. 78--.+. 8% CIVD, with Ps. w~hout 
concominant pit pertusion, for 10 -s, 10 -7 and 10 .8 MAch, reapectively (n 
: 4, p < 0.05). Dtmsthyithiourea (DMTU), a lipid soluble hydroxyl ~¢l~cal 
scavenger restored the ability of CyA pits to mediate vesodilalion: 17 :E 
7=/= ,vs. -4.5 4- 1.4% CWD, (n = 7, p < 0.05), while superoxlde dismutase 
(SOD) and catalase did not. Similarly, DMTU restored the ability of CyA 
exposed NL pits to cause vasedilalion, wh~e SOD and catslase did not. 
Condusion: Activated CyA-pits release free radical(s) which interfere with 
piatslstomedialed endothelium-dapendant vasndilatlon. 
1945--'4"5~ Discordant Effects o f  Acetylchollne, Substance P, 
end Adenosine in the Assessment o f  Cardiac 
AUograft Endothelial Function 
John H. Drury, Thomas Donohue, Rtcherd G. Bach, Leslie W. Miller, Morton 
J. Kern, Thomas L. Wolford. St. Louis University Health Sciences Center, 
St. Louis, MO 
Endothelial dysfunction is considered central to the pathogenesis of trans- 
plant coronary arteriopethy. Previous studies have used Acetylcholine (ACH) 
or Substance P (SP) to assess allograft coronary endothelium Integrity with 
conflicting results. Therefore, to study these agents in the same allagraft, we 
compared eplcardial vessel diameter (EVD) and coronary blood flow (CBF) 
responses to intracoronary infusions of ACN (10 -6 M), SP (22.4 pmoles), 
Adenosine (ADEN 10 -= M) and Saline (CON) in 18 transplant recipients (5.1 
+ 2.8 yrs post-transplant). A total of 54 segments were analyzed (3/pt). Mid 
segment EVD (quantitative coronary angiography) and blood flow velocity 
(Doppler guidewire) were used to derive CBF (average peak velocity x 0.5 
x cress-sectional area). 
ACH SP ADEN CON 
%AEVD 0.3±1.8 7.94-1.8" 12.64-2.1 0.94-1~0 
%ACBF 180±26" 164-9 § 3784-34 4.7±3.4 
*p = 0.005 vs ACH, "p:  0.02 v,J ADEN, §p = NS vS CON, §p < 0.0001 vs ACH. **p - 0. 
002 vs ADEN 
Cardiac allografts had abnormal epicardial vessel responses to ACH 
yet exhibited preserved endothelium-dependent epicardial vasodilation to 
SP and flow {ADEN). There were discordant CBF responses to the two 
endsthalial-dependent agents with an intact response to ADEN. Flow-mediated 
vasodilafory effects must be considered when using AGH to evaluate en- 
dothelial function. These discordant respenses must also be considered 
when these agents are used to characterize ndothelial integrity in the hu- 
man cardiac aifograft. 
~ R o l e  of Nitric Oxide in Myocardial  Ischemla and 
Reperfuaion Injury in • Heterotopic Rat Heart 
Transplantation Model 
Gaber Szal~, Sander B~it~i, Ralner Zlmmerrnann, Siegfried Hagl. 
University of Heidelberg, Germany 
Global myocardial ischemla and repeduslon injury play a major role In early 
postoperative graft dysfunction. In the present study, the influence of nt- 
trio oxide (NO) on ischemle/raporfusion injury and catochalamine sensitivity 
was investigated In a hetemtopic rat heart transplantation model. After one 
hour ischemlc preservation, reperfusion was started either after application 
of placebo (n = 8, control) or nltro-L-arginlne methyl ester (L-NAME, 10 
mg/kg, n = 8) for inhibition of NO synthesis. Myocardial blood flow (MBF), 
left vantdcular pressure (LVP), its first derivative (dP/dt), end diastOlic pres- 
sure (LVEOP) and lsovolumic relaxation constant O's) were measured after 
60 minutes reperfusion and with subsequent dobutamine (O) infusion (5 
/zg/kg/min). One,day graft survival was decreased after L-NAME (5•8 after 
L-NAME vs 8/8 in control). MBF was significantly decreased after L-NAME 
(1.2 4- 0.1 ve 1.g =t: 0.2 mVmlrVg, p < 0.05). The L-NAME group showed a 
decreased systolic function (maximal LVP: 53.2 4- 6 vs 86.5 ± 7 mmHg, p < 
0.05; maximal dP/dt: 1257 ± 290 vs 3410 4- 257 mmHg/s, p < 0.05) and a 
significant leftward shift of the LVEDP-Isft ventricular volume curve (LVEDP: 
12.57 ~- 1.4 vs 4.76 ~ 0.8 mmHg, p < 0.05 at a reference volume of 80 ,#). 
Myocardial relaxation was prolonged after L-NAME (TE: 23.8 -4- 3.1 vs 11.3 
± 1.6 ms, p < 0.05). D increased LVP, dP/dt and"Is in beth groups, however, 
this increase was smaller in the L-NAME group (p < 0.05). MBF remained 
unchanged with O In the L-NAME group and increased in the control group 
(1.2 ± 0.2 vs 2.7 4- 1.9 vs ml/mln/g, p < 0.05). These results indicate that 
1) NO productton within the graft during repeduslon represents a substan- 
tial determinant of graft function, 2) NO formation plays an Important role 
in #.edrenerglc responses of the mtcrevasculafure in the graft after heart 
transplantation. 
Cardiac AIIograft Mlcrovesculer Dysfunction 
uorraletes With • Peripheral Marker of  
Immunocyte Actlvctlon 
Richard G. Bach, Thomas Wolford, Thomas J. Donohue, John H. Drury, 
Eugene A. Carascloto, Frank V. Agulrre, Morton J. Kern, Leslie W. Miller. St. 
Louis University, St. Louis, MO 
Attograft artoriopathy after heart transplantation can involve beth eptcardial 
conduit and resistance vessels. The etiology remains unknown, although 
recent data has implicated an immunologic mechanism. To date, few studies 
have examined allogralt microvascular functional abnormalities. Therefore, 
we examined the association between abnormal allagraft coronary vasodila- 
for reserve (CVR) detected uring routine transplant follow-up and markers 
of immune activation. CVR (hyperemic/basal mean flow velocity) was de- 
termined by Doppler guidewire and adenosine in 347 coronary arteries in 
170 pts at catheterization. Peripheral blood was analyzed by flow cytome- 
try for determination of percentage of activated T cells (T4 cells expressing 
Interleukin-2 receptor by anti-CD25, % T4-1L2R+). Concurrent biopsy re- 
jection grade (numerical conversion of ISHLT grade, BxGRD) and number 
of previous treated rejection episodes (#+REJ) were also analyzed. CVR 
was considered abnormal at < 2.0 (> 1SD below mean In normal artedas). 
Results (mean :1= SEM): 
(n) # + REJ B x GRD % T4-1L2R+ 
CVR > 2.0 312 1.9 4. 0.1 1.04. 0.1 10.0 + 1 
C~ < 2.0 ~ ~.~ ~ ~1 ~ 1.2±0.2 22.54-3 
p value 0.as 0.41 0.00S 
Notably, % T4-1L2R+ was significantly higher when CVR was reduced 
at < 2.0. Reduced CVR was not correlated with acute cellular rejection or 
with a history of previously treated rejection episodes. These results suggest 
that microvascular dysfunction in cardiac allografts may result from activated 
T-cog-mediated mechanisms, independent of rejection, of which peripheral 
IL-2R quantitatlon may provide a useful marker. 
Inducible Nitric Oxide Synthase Is Expressed 
uurmg P.arly and Late Experimental Acute Cardiac 
AIIograft Rejection 
Nell K. Worrall, Thomas P. Misko, Jia J. Hut, Patrick M. Sullivan, T. 
Bruce Ferguson Jr.. Washington University, St. Louis, 1t40; Monsanto Co., 
St. Louis, MO 
We have recently demonstrated that 1 ) inducible nitric oxide synthase (iNOS) 
is expressed dudng acute cardiac allograft rejection end 2) inhibition of nitric 
oxide (NO) production by iNOS attenuates acute rejection. This study deter- 
mined the time-coume of INOB mRNA and protein expression dudng acute 
rejection. Using a hetsmfopic rat model, grafted heart tissue from isogrefts 
(ACI to ACI) and allagrefts (Lewis to ACI) was harvested at serial time-points 
pest-tranaplantstion. INO$ mRNA (detected by dbonuctease protection as- 
say) was weakly present in allogrefts on POD-3 (minimal rejection), was 
strongly present on POD-4, -6, -8, and -10 (mild to complete rejection, re- 
spectively), but was not present in isogrefts on POD-6 or -8 or in normal 
controls, iNOS enzyme activity (measured as conversion of L-[ a H]-arginine 
to NO and L-p H]-citrulline) was higher in allagrefts on POD-4, -6, -8, and 
-10 (9.0:1: 2.3, 5.1 4- 1.0, 5.7 =1: 1.6, and 4.3 • 0.7 pmol L-citrulllne/mg 
protein/rain, respectively) than in aifografts on POD-3 (0.6 4- 0.3), in isografts 
on POD-6 or-8 (0.1 ± 0.1 and 0.2 4- 0.1), or in controls (0.1 d: 0.1; mean 
4- SEM; n = 4-8; P < 0.01 by ANOVA). Serum nltdte/nltrete l vels, which 
reflect endogenous NO production, were higher in allografts on POD-4, -6, 
and -8 (45 4- 7, 57:1: 5, and 33 4- 1 p.M, respectively) than in allografts on 
POD-3 (20 :t: 2), in isografts on POD-4, -6 or .8 (22 4- 2, 22 4- 4, and 14 4- 
1), or in controls (15 ± 1; mean :l: SEM; n = 4--12; P < 0.01 by ANOVA). 
Thus INOS mRNA and protein expression first occur dudng the early stages 
of acute rejection and pore{st throughout he unmodified rejection process. 
Increased NO production, detected by the presence of INOS mRNA, protein, 
or noninvasively by measuring serum nitdte/nitrste l vels, may ,;'erve as an 
early marker of acute cardiac altograft rejection. 
